MedTrace Logo

Fibre-optic Guided Tracheal Intubation Through SADs

NCT03118596 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2020-04-09

Study results available
· View outcomes & findings →

Summary

The study aims to establish which of the two second generation Supraglottic Airway Devices, the I-gel or the the laryngeal ask airway (LMA) Protector, is best suited to be used as a conduit to fibreoptic bronchoscope assisted tracheal intubation. The primary outcome of this will be the time to complete the tracheal intubation.

Conditions

  • Intubation; Difficult or Failed
  • Laryngeal Masks
  • Airway Management

Interventions

DEVICE

I-gel

Fibreoptic guided tracheal intubation is going to be performed through the I-gel supraglottic airway.

DEVICE

LMA Protector

Fibreoptic guided tracheal intubation is going to be performed through the LMA Protector supraglottic airway.

Sponsors & Collaborators

  • University Hospitals Coventry and Warwickshire NHS Trust

    lead OTHER

Principal Investigators

  • Cyprian Mendonca, Prof. · University Hospitals Coventry & Warwickshire NHS Trust, Clifford Bridge Road, Coventry CV2 2DX

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-24
Primary Completion
2018-03-26
Completion
2018-03-26

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03118596 on ClinicalTrials.gov